Sort
82,697 grants matching “vaccine development”
The WWAMI RCE for Biodefense and Emerging ID
$11,677,224University Of Washington · U54 · FY2004 · AI
Development of immunology and immunization strategies that induce broadly pro
$11,675,740Dennis R. Burton · Scripps Research Institute, The · UM1 · FY2014 · AI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)
$11,669,860David S Stephens · Emory University · UM1 · FY2022 · AI
Animal Medicine Infrastructure Support - Animal Care
$11,646,878Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIG · FY2025 · AI
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) - DOC
$11,598,959James J. Korelitz · Westat, Inc. · U01 · FY2013 · HD
Region VI Center for Biodefence and Emerging Infections
$11,566,950University Of Texas Medical Br Galveston · U54 · FY2004 · AI
DCTD Biopharmaceutical Development
$11,541,306Larry Arthur · Science Applications International Corp · N01 · FY2009 · CA
International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group
$11,508,822J Brooks Jackson · Social And Scientific Systems, Inc. · UM1 · FY2011 · AI
Production of a Broadly Neutralizing HIV Antibodies
$11,507,499Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2016 · AI
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: CLINICAL CORE
$11,506,068Kathleen Neuzil · University Of Maryland Baltimore · N01 · FY2020 · AI
National Emerging Infectious Diseases Laboratories Operations
$11,500,000Nancy Jean Sullivan · Boston University Medical Campus · UC7 · FY2022 · AI
National Emerging Infectious Diseases Laboratories Operations
$11,500,000Nancy Jean Sullivan · Boston University Medical Campus · UC7 · FY2023 · AI
National Emerging Infectious Diseases Laboratories Operations
$11,500,000Ronald B Corley · Boston University Medical Campus · UC7 · FY2020 · AI
Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trial Not Allowed)
$11,500,000Gene Garrard Olinger · University Of Texas Med Br Galveston · UC7 · FY2024 · AI
Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trial Not Allowed)
$11,500,000Gary Kobinger · University Of Texas Med Br Galveston · UC7 · FY2021 · AI
Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trial Not Allowed)
$11,500,000Gene Garrard Olinger · University Of Texas Med Br Galveston · UC7 · FY2025 · AI
National Emerging Infectious Diseases Laboratories Operations
$11,500,000Ronald B Corley · Boston University Medical Campus · UC7 · FY2016 · AI
National Emerging Infectious Diseases Laboratories Operations
$11,500,000Ronald B Corley · Boston University Medical Campus · UC7 · FY2021 · AI
National Emerging Infectious Diseases Laboratories Operations
$11,500,000Nancy Jean Sullivan · Boston University Medical Campus · UC7 · FY2024 · AI
National Emerging Infectious Diseases Laboratories Operations
$11,500,000Robert A Davey · Boston University Medical Campus · UC7 · FY2025 · AI
National Emerging Infectious Diseases Laboratories Operations
$11,500,000Ronald B Corley · Boston University Medical Campus · UC7 · FY2019 · AI
Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trial Not Allowed)
$11,500,000Gary Kobinger · University Of Texas Med Br Galveston · UC7 · FY2022 · AI
Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trial Not Allowed)
$11,500,000Gary Kobinger · University Of Texas Med Br Galveston · UC7 · FY2023 · AI
Vaccine and Treatment Evaluation Units
$11,432,119Nadine Georges Rouphael · Emory University · UM1 · FY2020 · AI
The WWAMI RCE for Biodefense and Emerging ID
$11,401,047Samuel I. Miller · University Of Washington · U54 · FY2008 · AI